Edit |   |
---|---|
Antigenic Specificity | CD279, Human (Nivolumab biosimilar) |
Clone | Nivolumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD279 Recombinant Antibody (Nivolumab). Nivolumab, sold under the brand name Opdivo, is a medication used to treat a number of types of cancer. |
Immunogen | n/a |
Other Names | Anti-CD279 Recombinant Antibody, Research Grade Nivolumab, Anti-Human CD279 Recombinant Antibody(Nivolumab), BMS-936558, MDX-1106, Antibody Drug Analogues, Monoclonal Antibody, YR1010, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 946414-94-4 |
Catalog # | YR1010 |
Price | please inquire |
Order / More Info | CD279, Human (Nivolumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |